Non-transplant surgical interventions for emphysema
Anthony P C Yim 嚴秉泉
HK Pract 2007;29:41-42
Emphysema is one of the very common chronic diseases seen among the elderly population
often caused by smoking, and is responsible for billions of dollars in healthcare
expenses every year. The commonest symptom of emphysema is chronic dyspnoea which
could be very debilitating, and seriously affect one's quality of life. Medical
therapy has only limited success. For a long time until recently, emphysema has
not been considered a surgical condition except for transplantation which can only
benefit a very tiny fraction of patients. In fact, it may be counter-intuitive to
imagine that such a disease could have a mechanical solution.
Emphysema is one of the very common chronic diseases seen among the elderly population
often caused by smoking, and is responsible for billions of dollars in healthcare
expenses every year. The commonest symptom of emphysema is chronic dyspnoea which
could be very debilitating, and seriously affect one's quality of life. Medical
therapy has only limited success. For a long time until recently, emphysema has
not been considered a surgical condition except for transplantation which can only
benefit a very tiny fraction of patients. In fact, it may be counter-intuitive to
imagine that such a disease could have a mechanical solution. In this issue of The
Hong Kong Practitioner, Sihoe and Chan are to be congratulated for giving us an
overview on this new, exciting field of surgical intervention for emphysema. The
basic pathophysiology of this condition is the loss of elastic recoil, and as the
total lung volume increases, the diaphragms are pushed down and cannot function
properly. By reducing the lung volume, the respiratory mechanics (including functioning
of the diaphragms) is greatly improved. The current options available include lung
volume reduction surgery (LVRS) and placement of endobronchial valves (EBV) - the
former involves surgical removal of the most emphysematous, functionless lung tissue,
and the latter involves bronchoscopic placement of one-way valves in the airway
to achieve selective atelectasis or "medical" lung volume reduction. Both options
require identification of target areas in the lung - a heterogeneous pattern of
emphysema. CT thorax and ventilation perfusion (VQ) scan are useful tests in selecting
patients for surgical intervention. The published intermediate and long term results
(including those from our unit) for both LVRS and EBV for selected patients are
most encouraging.1
A multi-disciplinary approach is crucial to the success of emphysema surgery. A
dedicated team of pulmonologist, physiotherapist, anaesthetist, intensivist and
surgeon is important in selecting patients, preparing them for surgery and providing
perioperative care. Family physicians also play a critical role in the care of patients
with emphysema as they can help to select patients as well as participating in the
follow up. They should be kept up to date with the current and emerging treatment
modalities for this debilitating condition. Hopefully, by working together, we can
bring back quality of life to these unfortunate patients with emphysema.
Anthony P C Yim, DM(Oxon), FRCS(Eng, Edin, Glasg), FHKAM(Surgery), Specialist
in Cardiothoracic Surgery
Professor of Surgery,
The Chinese University of Hong Kong.
Director
Minimally Invasive Centre, Union Hospital.
Correspondence to : Professor Anthony P C Yim, Department of Surgery, The
Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, N.T., Hong Kong.
Email: yimap@cuhk.edu.hk
References
- Hwong TMT, Yim APC. New treatment modalities for end-stage emphysema. Chest Surg
Clin N Am 2003;13:739-753
|